247 related articles for article (PubMed ID: 16818455)
1. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
Maron BJ; Olivotto I; Maron MS
Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
[No Abstract] [Full Text] [Related]
2. Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy.
Elliott P; Gimeno J; Tomé M; McKenna W
Eur Heart J; 2006 Dec; 27(24):3073; author reply 3073-4. PubMed ID: 17121751
[No Abstract] [Full Text] [Related]
3. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
[TBL] [Abstract][Full Text] [Related]
4. [Hypertrophic cardiomyopathy in 2013].
Giannakopoulos G; Frangos C
Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110
[TBL] [Abstract][Full Text] [Related]
5. Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.
Efthimiadis GK; Parcharidou DG; Giannakoulas G; Pagourelias ED; Charalampidis P; Savvopoulos G; Ziakas A; Karvounis H; Styliadis IH; Parcharidis GE
Am J Cardiol; 2009 Sep; 104(5):695-9. PubMed ID: 19699347
[TBL] [Abstract][Full Text] [Related]
7. Ethanol and hypertrophic cardiomyopathy.
Allan JJ
N Engl J Med; 1997 Mar; 336(12):878. PubMed ID: 9072690
[No Abstract] [Full Text] [Related]
8. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophic cardiomyopathy and outflow tract obstruction.
Spevack DM
N Engl J Med; 2003 May; 348(18):1815-6; author reply 1815-6. PubMed ID: 12728916
[No Abstract] [Full Text] [Related]
10. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice. Hypertrophic obstructive cardiomyopathy.
Nishimura RA; Holmes DR
N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
[No Abstract] [Full Text] [Related]
12. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
Maron BJ
Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
[No Abstract] [Full Text] [Related]
13. My approach to clinical management of hypertrophic cardiomyopathy.
Maron MS
Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
[No Abstract] [Full Text] [Related]
14. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
Maron BJ
Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254
[No Abstract] [Full Text] [Related]
15. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
[TBL] [Abstract][Full Text] [Related]
17. [Evolution of the surgical strategy in hypertrophic cardiomyopathy: case studies of eight patients].
Joudinaud T; Flecher E; Hvass U
Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):16-21. PubMed ID: 18054343
[TBL] [Abstract][Full Text] [Related]
18. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
[No Abstract] [Full Text] [Related]
19. Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
Maron BJ; Rowin EJ; Maron MS
Am J Med; 2020 Aug; 133(8):886-888. PubMed ID: 32741446
[No Abstract] [Full Text] [Related]
20. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
[No Abstract] [Full Text] [Related]
[Next] [New Search]
